DTwP-HB-Hib: antibody persistence after a primary series, immune response and safety after a booster dose in children 18–24 months old
Abstract Background The new combination of DTwP-HB-Hib vaccines has been developed in Indonesia following World Health Organization (WHO) recommendation and integrated into national immunization program. The aims of the study were to measure 1) antibody persistence 12–18 months after a primary serie...
Main Authors: | Hartono Gunardi, Kusnandi Rusmil, Eddy Fadlyana, Soedjatmiko, Meita Dhamayanti, Rini Sekartini, Rodman Tarigan, Hindra Irawan Satari, Bernie Endyarni Medise, Rini Mulia Sari, Novilia Sjafri Bachtiar, Cissy B. Kartasasmita, Sri Rezeki S. Hadinegoro |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | BMC Pediatrics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12887-018-1143-6 |
Similar Items
-
The immunogenicity and safety of the new, Indonesian DTwP-HB-Hib vaccine compared to the DTwP/HB vaccine given with the Hib vaccine
by: Novilia Sjafri Bachtiar, et al.
Published: (2017-06-01) -
The quantity and quality of anti-PRP induced by the new Indonesian DTwP-HB-Hib vaccine compared to the Hib vaccine given with the DTwP-HB vaccine
by: Novilia Sjafri Bachtiar, et al.
Published: (2018-01-01) -
THE SAFETY OF HAEMOPHILUS INFLUENZAE TYPE B/POLYRIBOSYLRIBITOL PHOSPHATE-TETANUS (HIB/PRP-T) VACCINE, PHASE I STUDY
by: Kusnandi Rusmil, et al.
Published: (2015-09-01) -
Safety and immunogenicity of the DTP/HB /Hib combination vaccine: phase I study
by: Kusnandi Rusmil, et al.
Published: (2013-12-01) -
Incidência de episódios hipotônicos-hiporresponsivos associados à vacina combinada DTP/Hib usada no Programa Nacional de Imunizações Incidence of hypotonic-hyporesponsive episodes associated to the combined DTP/Hib vaccine used in Brazilian National Immunizations Program
by: Reinaldo M. Martins, et al.
Published: (2007-12-01)